Search Within

Adilia Hormigo

Formats
  1. Meeting Abstract (25)
  2. Journal Article (23)
  3. Book Section (1)
Groups
  1. Tow Center for Developmental Oncology (TCDO) (28)
  2. Biostatistics Service (16)
  3. Epidemiology and Biostatistics (16)
  4. Population Sciences Research Program (16)
  5. Radiology, Department of (12)
  6. Surgery (12)

More Groups

People
  1. Lisa De Angelis (28)
  2. Lauren Abrey (21)
  3. Andrew Lassman (16)
  4. Katherine Panageas (16)
  5. Igor Gavrilovic (14)
  6. Craig Nolan (13)

More People

Years
  1. 2016 (1)
  2. 2014 (1)
  3. 2013 (2)
  4. 2012 (1)
  5. 2011 (9)
  6. 2010 (2)

More Years

Publications
  1. Neuro-Oncology (17)
  2. Journal of Clinical Oncology (12)
  3. Journal of Neuro-Oncology (5)
  4. Clinical Cancer Research (3)
  5. Annals of Neurology (2)
  6. Archives of Neurology (1)

More Publications

Publishers
  1. Oxford University Press (17)
  2. American Society of Clinical Oncology (12)
  3. Springer (6)
  4. American Association for Cancer Research (3)
  5. Elsevier Inc. (2)
  6. Wiley Blackwell (2)

More Publishers

Results (49)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas
    Journal Article

    Iwamoto, F. M.; Hottinger, A. F.; Karimi, S.; Riedel, E.; Dantis, J.; Jahdi, M.; Panageas, K. S.; Lassman, A. B.; Abrey, L. E.; Fleisher, M.; more...
    Journal of Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas
    Journal Article

    Iwamoto, F. M.; Hottinger, A. F.; Karimi, S.; Riedel, E.; Dantis, J.; Jahdi, M.; Panageas, K. S.; Lassman, A. B.; Abrey, L. E.; Fleisher, M.; more...
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma
    Journal Article

    Hottinger, A. F.; Iwamoto, F. M.; Karimi, S.; Riedel, E.; Dantis, J.; Park, J.; Panageas, K. S.; Lassman, A. B.; Abrey, L. E.; Fleisher, M.; more...
    Annals of Neurology (2011)

    Fulltext@MSK | Save
  • A target for antiangiogenic therapy: Vascular endothelium derived from glioblastoma
    Journal Article

    Hormigo, A.; Ding, B. S.; Rafii, S.
    Proceedings of the National Academy of Sciences of the United States of America (2011)

    Fulltext@MSK | Save
  • Phase II trial of continuous low-dose temozolomide (TMZ) for recurrent malignant glioma (MG) with and without prior exposure to bevacizumab (BEV)
    Meeting Abstract

    Khasraw, M.; Abrey, L. E.; Lassman, A. B.; Hormigo, A.; Nolan, C.; Gavrilovic, I. T.; Mellinghoff, I. K.; Reiner, A. S.; DeAngelis, L. M.; Omuro, A. M.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save
  • Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice
    Journal Article

    Shmelkov, S. V.; Hormigo, A.; Jing, D.; Proenca, C. C.; Bath, K. G.; Milde, T.; Shmelkov, E.; Kushner, J. S.; Baljevic, M.; Dincheva, I.; more...
    Nature Medicine (2010)

    Fulltext@MSK | Save
  • A placebo-controlled study investigating the dexamethasone-sparing effects of corticorelin acetate in patients with primary or metastatic brain tumors and peritumoral edema
    Meeting Abstract

    Recht, L. D.; Mechtler, L.; Phuphanich, S.; Hormigo, A.; Hines, V.; Milsted, R.; O'Connor, P. C.; Ryan, R. P.; Wong, E. T.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A long-term open-label extension study examining the steroid-sparing effects of corticorelin acetate in patients with cerebral tumors
    Meeting Abstract

    Mechtler, L.; Wong, E. T.; Hormigo, A.; Pannullo, S.; Hines, V.; Milsted, R.; O'Connor, P. C.; Ryan, R. P.; Recht, L.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma
    Journal Article

    Clarke, J. L.; Iwamoto, F. M.; Sul, J.; Panageas, K.; Lassman, A. B.; DeAngelis, L.; Hormigo, A.; Nolan, C. P.; Gavrilovic, I.; Karimi, S.; more...
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Expression of CD133+ in the brain of a mouse model with a lacZ reporter knock-in at the CD133 locus
    Meeting Abstract

    Hormigo, A.; Shmelkov, S. V.; Hooper, A. T.; Butler, J.; Lyden, D.; Rafii, S.
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save